Khambatta Securities' research report on Emami
Emami delivered robust sales growth of ~18% y-o-y in 1Q FY23, driven by the Dermicool brand (acquired in March this year) to a large extent. Excluding Dermicool, sales growth was ~10% in the quarter. With 90% of Dermicool sales generated in 1Q and the remainder 10% in 2Q, revenues will be driven by other products in the coming quarters of the current financial year. Margins witnessed pressure due to higher raw material costs, which increased CoGS as a percentage of operating revenues by ~340 bps in 1Q FY23. We have marginally adjusted our margin assumptions based on the latest data-points. The Emami stock witnessed robust appreciation, followed by subsequent corrections to stand at 27% higher, since we initiated coverage on the company with a BUY rating on 23 September 2020. Since our last update report dated 18 May 2022, the stock has gained 6%.
Outlook
The Emami stock is currently trading at an attractive valuation of ~26x FY24E. We maintain a BUY rating on Emami with a price target of Rs 595 (reduced from Rs 601) based on P/E of 34x FY24E EPS, informing a 28% upside from current levels.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.